LOGIN  |  REGISTER
Assertio
Terns Pharmaceuticals

Phreesia’s Dan Nathan Named as a Top Software CTO of 2023

March 15, 2023 | Last Trade: US$23.97 0.08 0.33

WILMINGTON, Del. / Mar 15, 2023 / Business Wire / Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Dan Nathan, the company’s Chief Technology Officer, has been named to The Software Report’s list of the Top 25 Software CTOs of 2023.

Honorees were selected based on a proven record of high performance in leading teams to deliver solutions that streamline operations, improve efficiency and interpret data, enhancing overall business operations. This year’s list of 25 CTOs represent the driving force behind their companies’ technical capabilities, ensuring software product functionality and effectiveness.

“As technology continues to change and disrupt the way we do business, the importance of having a skilled and visionary CTO cannot be overstated,” The Software Report said in its announcement. “The CTOs being recognized on this year’s awardees list have made significant contributions to their organizations proven by a track record of success.”

In his role, Nathan oversees Phreesia’s core and integration platforms, and is responsible for the company’s Patient Intake, Data Center Operations, Site Reliability Engineering and Analytics teams. Phreesia facilitates more than 100 million patient visits annually, and Nathan’s hands-on leadership has helped propel the company’s growth and success as a leading patient intake management platform. Nathan joined Phreesia nearly 16 years ago, serving as an Architect and then Vice President of Engineering before being named CTO in 2019.

“It’s truly an honor to be recognized by The Software Report as one of the Top 25 Software CTOs,” said Nathan. “At Phreesia, we strive to help patients take a more active role in their care and improve health outcomes, and I’m proud to lead a team that is focused on driving this mission forward.”

For more information on Phreesia, visit www.phreesia.com.

About Phreesia

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency. For more information, visit Phreesia.com.

Assertio

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page